CERo Therapeutics has reported early clinical findings from its ongoing Phase 1 CertainT-1 trial evaluating CER-1236 in patients with acute myeloid leukemia, highlighting initial safety observations and a platelet transfusion-free interval in a patient wi... See more
Breast cancer remained the world’s most studied disease for the fifth consecutive year in 2025, according to a new annual analysis from clinical data analytics company Phesi.
The findings are based on an analysis of 65,892 recruiting clinical trials captu... See more
TECregen raises CHF 10m (EUR 10.7m) seed financing and appoints Dr Bo Rode Hansen as chairman
TECregen, a biotechnology company focused on thymus regeneration, has completed a CHF 10 million (EUR 10.7 million / USD 12.6 million) seed financing round and a... See more
Pharmapack will return to Paris in January 2026, with this year’s programme set to focus on pharmaceutical packaging challenges linked to the rapid growth of GLP-1 therapies and increasing sustainability requirements.
The event will take place at Paris Ex... See more
ViCentra expands Series D financing to $98m to support Kaleido insulin patch pump rollout
ViCentra has expanded its Series D financing round to $98m, following the addition of $13m in new and existing investment to support European commercial growth and p... See more
